U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756346) titled 'A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis Suppurativa' on Aug. 04.
Brief Summary: This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease hidradenitis suppurativa (HS). In this study, the investigators will extend data from a 12-week pilot study to rigorously test the hypothesis that botulinum toxin (BoNT) therapy reduces disease severity and relieves HS pain symptoms..
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa (HS)
Intervention:
DRUG: Botulinum ...